GURUFOCUS.COM » STOCK LIST » USA » NAS » Illumina Inc (NAS:ILMN) » Definitions » Median PS Value
Switch to:

Illumina Median PS Value

: $390.16 (As of Today)
View and export this data going back to 2000. Start your Free Trial

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Illumina's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 was $29.972. Illumina's 10-Year median PS Ratio is 13.0175. Therefore, the Median PS Value for today is $390.16.

As of today (2022-08-16), Illumina's share price is $220.055. Illumina's Median PS Value is $390.16. Therefore, Illumina's Price to Median PS Value for today is 0.57.

The historical rank and industry rank for Illumina's Median PS Value or its related term are showing as below:

ILMN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.44   Med: 1.16   Max: 1.92
Current: 0.57

During the past 13 years, the highest Price to Median PS Value of Illumina was 1.92. The lowest was 0.44. And the median was 1.16.

ILMN's Price-to-Median-PS-Value is ranked better than
66.67% of 81 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.87 vs ILMN: 0.57

Illumina Median PS Value Historical Data

The historical data trend for Illumina's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Illumina Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Median PS Value
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 185.78 232.66 264.71 268.64 390.19

Illumina Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Median PS Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 340.86 372.68 390.19 393.53 390.16

Competitive Comparison

For the Diagnostics & Research subindustry, Illumina's Median PS Value, along with its competitors' market caps and Median PS Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Illumina Median PS Value Distribution

For the Medical Diagnostics & Research industry and Healthcare sector, Illumina's Median PS Value distribution charts can be found below:

* The bar in red indicates where Illumina's Median PS Value falls into.



Illumina Median PS Value Calculation

Illumina's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=29.972*13.0175
=390.16

10-Year Median PS Ratio is 13.0175.
Illumina's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $29.972.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Illumina  (NAS:ILMN) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Illumina's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=220.055/390.16
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Illumina Median PS Value Related Terms

Thank you for viewing the detailed overview of Illumina's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Illumina Business Description

Illumina logo
Address
5200 Illumina Way, San Diego, CA, USA, 92122
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates revenue from sequencing tools and dedicated consumables (76% of 2020 sales). Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications. Services account for 16% of sales and include basic maintenance services, clinical lab applications (such as noninvasive prenatal, oncology, and rare-disease screening), and whole genome sequencing.
Executives
Frank John Edward officer: Chief Public Affairs Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Rollins Carissa officer: SVP, Chief Information Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Pegels Kevin Carl officer: Chief of Global Operations 5200 ILLUMINA WAY SAN DIEGO CA 92122
Torres Jose officer: VP, Chief Accounting Officer 1300 W. 120TH AVENUE WESTMINSTER CO 80234
Reeves Kathryne Gambrell officer: SVP, Chief Marketing Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Aravanis Alexander officer: SVP, Chief Technology Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Gottlieb Scott director MOLECULAR INSIGHT PHARMACEUTICALS 160 SECOND STREET CAMBRIDGE MA 02142
Febbo Phillip G. officer: SVP Chief Medical Officer C/O GENOMIC HEALTH, INC. 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063
Tousi Susan H officer: SVP Product Development 5200 ILLUMINA WAY SAN DIEGO CA 92122
Goswami Joydeep officer: SVP Corp Business Development SUMITOMO FUDOSAN MITA TWIN BLDG EAST WING 4-2-8 SHIBAURA MINATO-KU TOKYO M0 1080023
Siegel Susan E director 3000 SAND HILL ROAD BLDG 3 STE 290 MENLO PARK CA 94025
Ragusa Robert P officer: SVP, Global Quality & Ops
Hoyt Aimee L officer: SVP, Chief People Officer 5200 ILLUMINA WAY SAN DIEGO CA 92122
Guthart Gary S director C/O INTUITIVE SURGICAL INC 1266 KIFER RD SUNNYVALE CA 94086
Mcginnis Karen K officer: VP, Chief Accounting Officer INSIGHT ENTERPRISES INC 1305 WEST AUTO DRIVE TEMPE AZ 85284

Illumina Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)